These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12531353)

  • 1. Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance.
    Pavlova BG; Loew-Baselli A; Fritsch S; Poellabauer EM; Vartian N; Rinke I; Ehrlich HJ
    Vaccine; 2003 Jan; 21(7-8):742-5. PubMed ID: 12531353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
    Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
    Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
    Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
    Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
    Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
    Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine.
    Pöllabauer EM; Fritsch S; Pavlova BG; Löw-Baselli A; Firth C; Koska M; Maritsch F; Barrett PN; Ehrlich HJ
    Vaccine; 2010 Jun; 28(29):4558-65. PubMed ID: 20452432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunogenicity and safety between two paediatric TBE vaccines.
    Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Prymula R; Angermayr R; Draxler W; Firth C; Bosman J; Valenta B; Harmacek P; Maritsch F; Barrett PN; Ehrlich HJ
    Vaccine; 2010 Jun; 28(29):4680-5. PubMed ID: 20433803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
    Steffen R; Erber W; Schmitt HJ
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
    Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
    Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study.
    Schosser R; Reichert A; Mansmann U; Unger B; Heininger U; Kaiser R
    Vaccine; 2014 Apr; 32(20):2375-81. PubMed ID: 24613521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions to tick-borne encephalitis vaccine: FSME-Immun.
    Grzeszczuk A; Sokolewicz-Bobrowska E; Prokopowicz D
    Infection; 1998; 26(6):385-8. PubMed ID: 9861565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactions after vaccination against tick-borne encephalitis].
    Vlasimská H; Smejkalová H
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):26-8. PubMed ID: 7757345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TBE--update on vaccination recommendations for children, adolescents, and adults.
    Jelinek T
    Wien Med Wochenschr; 2012 Jun; 162(11-12):248-51. PubMed ID: 22688621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the immune system by different TBE-virus vaccines.
    Marth E; Kleinhappl B; Jelovcan S
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():139-44. PubMed ID: 15146996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
    Kantele A; Rombo L; Vene S; Kundi M; Lindquist L; Erra EO
    Vaccine; 2022 Feb; 40(9):1299-1305. PubMed ID: 35101266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FSME monitoring: monitoring of adverse events of tick-borne-encephalitis vaccines by selected paediatricians and general practitioners].
    Weinzettel R; Ertl S; Zwiauer K
    Wien Med Wochenschr; 2007; 157(5-6):107-10. PubMed ID: 17427006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing tick-borne encephalitis.
    Demicheli V; Debalini MG; Rivetti A
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD000977. PubMed ID: 19160184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.